Published in Hypertension on October 24, 2005
Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension (2010) 1.04
Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J (2006) 0.93
Kallikrein activates bradykinin B2 receptors in absence of kininogen. Am J Physiol Heart Circ Physiol (2005) 0.89
Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling. Int J Hypertens (2012) 0.78
Effects of bradykinin on venous capacitance in health and treated chronic heart failure. Clin Sci (Lond) (2009) 0.75
Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev (1992) 4.56
Allosteric mechanisms of signal transduction. Science (2005) 4.55
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med (1998) 3.18
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem (1990) 2.41
Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). J Pharmacol Exp Ther (1971) 2.19
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J (2004) 1.98
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest (1997) 1.83
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Circ Res (2003) 1.69
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation (2005) 1.57
Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. J Biol Chem (2003) 1.50
RhoA interaction with inositol 1,4,5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability. J Biol Chem (2003) 1.43
Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry (1983) 1.37
Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension (2002) 1.33
A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein". J Biol Chem (1990) 1.33
A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci (1993) 1.31
Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem (1993) 1.27
N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension (1998) 1.21
Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res (2005) 1.15
Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases. Mol Pharmacol (2000) 1.14
Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension (1999) 1.11
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides (2004) 1.10
Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors. J Biol Chem (2000) 1.05
Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension (2004) 1.00
Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme. FEBS Lett (2003) 0.95
Enhancement of bradykinin and resensitization of its B2 receptor. Hypertension (1999) 0.92
Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc Natl Acad Sci U S A (1994) 0.91
ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci (2004) 0.89
Angiotensin-converting enzyme-2: a molecular and cellular perspective. Cell Mol Life Sci (2004) 0.87
Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin. J Mol Cell Cardiol (2002) 0.85
Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane. Int Immunopharmacol (2002) 0.82
Angiotensin II generated by a human renal carboxypeptidase. Biochem Biophys Res Commun (1986) 0.82
Purification and characterization of human converting enzyme (kininase II). Peptides (1981) 0.80
Soluble dextran complexes of kallikrein. Bradykinin and enzyme inhibitors. Biochem Pharmacol (1978) 0.80
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides (2004) 1.10
Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J Mol Biol (2004) 1.09
Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol Pharmacol (2004) 1.09
The discovery of captopril: reply. FASEB J (2004) 1.08
Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of Ser745. J Biol Chem (2007) 1.07
Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator. Int Immunopharmacol (2007) 1.05
Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension (2010) 1.04
Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem (2002) 1.02
Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension (2002) 1.00
Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient b1 signaling from B2 agonists. J Biol Chem (2008) 0.97
Kinins, the long march--a personal view. Cardiovasc Res (2002) 0.93
Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J (2006) 0.93
Activation of bradykinin B1 receptor by ACE inhibitors. Int Immunopharmacol (2002) 0.89
Kallikrein activates bradykinin B2 receptors in absence of kininogen. Am J Physiol Heart Circ Physiol (2005) 0.89
Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin. J Mol Cell Cardiol (2002) 0.85
Cross-talk between carboxypeptidase M and the kinin B1 receptor mediates a new mode of G protein-coupled receptor signaling. J Biol Chem (2011) 0.85
Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells. Biol Chem (2006) 0.84
Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells. J Pharmacol Exp Ther (2005) 0.84
Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain. J Mol Biol (2006) 0.83
Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release. Am J Physiol Heart Circ Physiol (2005) 0.83
Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor. Hypertension (2002) 0.83
Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane. Int Immunopharmacol (2002) 0.82
Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process. Am J Physiol Heart Circ Physiol (2009) 0.81
The ectodomain shedding of angiotensin-converting enzyme is independent of its localisation in lipid rafts. J Cell Sci (2003) 0.81
Carboxypeptidase M is a positive allosteric modulator of the kinin B1 receptor. J Biol Chem (2013) 0.79
Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output. Biol Chem (2013) 0.77
The kinin system: suggestions to broaden some prevailing concepts. Int Immunopharmacol (2002) 0.76
Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N. Biochem J (2005) 0.76
Effect of angiotensin-converting-enzyme inhibitors. Lancet (2002) 0.75
B2R of bradykinin activated by proteases. Hypertension (2003) 0.75
Regarding "German science and black racism--roots of the Nazi Holocaust". FASEB J (2008) 0.75